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Background and Purpose. It now appears clear that both HIV/AIDS and antiretroviral therapy (HAART) use are associated
with higher risk of cardiovascular disease such as stroke. In this study, we evaluated the prevalence, the risk factors, and the
cardiometaboliccomorbiditiesofstrokeinHIV/AIDS CentralAfrican patients.Methods.This hospital-basedcross-sectionalstudy
collected clinical, laboratory, and imaging data of black Central African heterosexual, intravenous drug nonuser, and HIV/AIDS
patients.Results.Therewere54menand62women,withafemaletomaleratioof1.2:1.Allweredeﬁnedbyhypercoagulabilityand
oxidativestress.Hemorrhagicstrokewasreported in1patient,ischemicstrokein17patients,andallstrokesubtypes in18patients
(15%).Younger age<45years (P = .003),autoimmunity(P<. 0001),and metabolicsyndromedeﬁned by IDF criteria (P<. 0001)
were associated with ischemic stroke. Conclusions. Clustering of several cardiometabolic factors, autoimmunity, oxidative stress,
and lifestyle changes may explain accelerated atherosclerosisand highrisk of stroke inthese young black Africans with HIV/AIDS.
Prevention and intervention programs are needed.
1.Background
Highly active antiretroviral therapy (HAART)plays a critical
role in suppressing viral titers and increasing CD4+ lympho-
cyte counts, which translate to signiﬁcant reduced morbidity
and mortality among HIV patients [1, 2]. It now appears
clear that both HIV infection itself and HAART use are
associated with higher risk of stroke and metabolic disorders
[3–5].
The available information on stroke in African HIV-
infected patients comes from South Africa [3].
The majority of Central African HIV-infected patients
do not have access to drugs of the ﬁrst line and are not
systematically on HAART till now. It is not established
whether the HIV infection itself [4], the progression from
asymptomatic to symptomatic HIV disease, aging, lifestyle
changes, reduction of deﬁning HIV disease infections and
tumors,ARVexposure,andtraditionalandnewcardiovascu-
lar risk factors directly cause stroke in Central African HIV-
infected patients. In these Africans, severe hypertension,
hyperuricemia, hyperglycemia, high levels of Dr. dimer and
ﬁbrinogen, smoking, excessive alcohol intake, Helicobacter2 ISRN Cardiology
pylori, bacterial pneumonia, age ≥ 60 years, pulse pressure ≥
60mmHg, low socioeconomic status(SES),and rainy season
are the risk factors of stroke [5–8].
The objectiveofthisstudywastoevaluatetheprevalence,
the risk factors, and the cardiometabolic comorbidities
of ischemic stroke among HIV-infected Central African
patients.
2.Methods
This cross-sectional study was carried out on HIV-infected
patients managed at the Department of Internal Medicine
of the Teaching Hospital of Kinshasa, DRC, over a period
from 1st January 2004 through 30th May 2008. The Teaching
Hospital of Kinshasa is 1500-bed public university hospital
that servesa blackurban population of6 million people. The
climate is tropical. The study protocol designed according to
the Helsinki Declaration II was approved by the local ethics
committee.
2.1. Data Collection. Anthropometry recorded weight,
height, waist circumference (WC), hip circumference (HC)
and body mass index (BMI = weight, kg/height, m2)u s i n g
standard methods in participants with light clothes and
without shoes as described elsewhere [6]. Blood pressure
(BP) including systolic blood pressure (SBP), diastolic blood
pressure (DBP), and pulse pressure (SBP-DBP) after the
participant had rested for 10 minutes seated in a quiet room,
was measured in the left arm with elbow ﬂexed at heart
level using an Omron HEM 705 electronic BP manometer
( O m r o nL i f eS c i e n c eC o .L t d ,T o k y o ,J a p a n ) .
Laboratory investigations included haemoglobin, hema-
tocrit, glucose, total cholesterol (TC), triglycerides (TG),
HDL-cholesterol (HDL-C), CD4+ count, uric acid, antibod-
ies against oxidized LDL-cholesterol, HIV RNA viral load,
serological tests for syphilis, Toxoplasma gondii, Helicobacter
pylori (H. pylori), herpes simplex virus, Cytomegalovirus,
Cryptococcus neoformans, varicella zoster, bacterial and fun-
gal cultures, D-Dimer, and protein C, cardiac enzymes, pro-
tein S, circulating immune complexes, and antiphospholipid
syndrome. Glucose levels were measured in fasting plasma
samples usingglucose-oxidasemethodandspectrophotome-
ter (Hospitex Diagnostics, Florence, Italy) with internal and
external quality control. Total cholesterol, HDL-cholesterol,
uric acid, and triglycerides were measured using enzymatic
colorimetric methods (Biom´ erieux, Marcy l’Etoile, France).
Antibodies against oxidized LDL-cholesterol were measured
using solid phase two-site enzyme immunoassay based on
the direct sandwich technique there are two genetic determi-
nants on the oxidized apolipoprotein B molecule (Mercodia
AB, Sylveniusgatan 8A, SE754 50, Uppsala, Sweden). H.
pylori infection was essayed by the determination of IgG
antibodies as described elsewhere. CD4+ lymphocyte cell
count was performed using CyFlow Counter (Partec GmbH;
Munstar, Germany). HIV RNAviral load was recorded using
PCR chain reaction (Nuclisens Easy Q HIV-1; Biom´ erieux,
Boxtel,TheNetherlands).AlltheLaboratory determinations
were documented to be valid and reliable. Cerebrospinal
ﬂuid (CSF) was not analyzed for pressure, aspect, and
chemistry as lumbar puncture was not indicated in absence
of meningitis.
Cardiovascular evaluation comprised clinical symptoms,
CKMB, troponin, electrocardiograms (ECG), transthoracic
echocardiography, and coronary angiograms.
Radiological investigations included chest radiograph,
brain CT scan, and carotid echo-Doppler studies using
7.5Mhz transducer of Biosound echographer (Biosound
Inc., Indianapolis, Ind, USA) and are described elsewhere.
2.2. Deﬁnitions. Total obesity was deﬁned by BMI ≥
25kg/m2 hypertension was deﬁned as SBP ≥ 140mmHg
and/or DBP ≥ 90mmHg [9] and/or treatment with anti-
hypertensive medication during the previous 2 weeks. Low
and high SES were deﬁned according to our previous
work [7]. Pulse pressure ≥ 60mmHg with carotid intima-
media thickness ≥1mm (population median) or carotid
plaque was considered a surrogate of arterial stiﬀness and
subclinical atherosclerosis [6]. Diabetes mellitus (DM)/type
2 was deﬁned by either self-report accompanied by use
of antihyperglycaemic medication the by elevated serum
glucose (fasting ≥126mg/dL or ≥7.0mmol/L) or by non-
fasting glucose ≥200mg/dL (≥11.1mmol/dL) [10]. Acute
myocardial infarction/ICD-9 410; ICD-10 121,122 and acute
stroke/ICD-9 434; ICD-10 163 or ICD-9 431,432; ICD-10
161,162 were deﬁned with the ICD-9 version and the criteria
of ESC/ACC and WHO. Stroke was deﬁned in accordance
with WHO criteria as “rapidly developing clinical signs
of focal, or at times global “as is coma or subarachnoid
haemorrhage; disturbance of cerebral function, lasting more
than 24 hours or leading to death with no apparent cause
other than vascular origin” [11]. The deﬁnitions of ischemic
stroke and haemorrhagic stroke were based on the criteria of
the National Institute of Neurological Disorders and Stroke.
The clinical diagnosis of stroke [12]w a sc o n ﬁ r m e do nC T
scan. Intracerebral space-occupying lesions otherthan stroke
on CT scan were not considered in the present study.
As detailed in the IDF report from April 2005 [13], par-
ticipants with three of the deﬁned criteria were considered as
having the metabolic syndrome.
The cardiometabolic consequences included arterial
hypertension, type 2 diabetes, myocardial infarction, stroke,
long QTc ≥ 0.420ms, gout/hyperuricaemia, and subclinical
atherosclerosis [14–16].
HIV-infection characteristics included ELISA HIV-1
seropositivity, CD4+ count, WHO stages [17], and HIV
disease status according to the 1993 CDC classiﬁcation of
HIV disease [18], type, and duration in years of ARV.
2.3. Statistical Analysis. Student’s t-test was performed to
assess diﬀerences between two means and ANOVA between
groups. Either chi-square test with and without trend or
Fischer’s exact test was used to test the degree of association
of categorical variables.
A P value <. 05 was considered statistical signiﬁcant.
All statistically analyses of database results were performed
with the Statistical Package for the Social Sciences (SPSS for
Windows, v.13; Chicago, Ill, USA).ISRN Cardiology 3
Table 1: Association between waist circumference (WC),hip circumference (HC), fasting glucose, hematocrit, pulse pressure, and ischemic
stroke amongHIV/AIDS patients.
Variables of interest Presence of ischemic stroke mean ± SD Absence of ischemic stroke mean ± SD P value
WC (cm) 119.6 ± 5.8 98.7 ± 19.2 <.0001
HC (cm) 118.8 ± 5.1 105.8 ± 16.6 .002
Fasting glucose (mg/dL) 140.4 ± 10.9 116.4 ± 36.9 .010
Hematocrit (%) 39.6 ± 0.04 32.9 ± 7.8 <.001
Pulse pressure (mmHg) 86.1 ± 8 47.1 ± 16.4 <.0001
CD4+ count (cells/mm3) 107.6 ± 1.7 207.6 ± 179.4 .024
Viral load 132.103 ± 12.103 132.103 ± 258.03 1.000
WC: waist circumference; HC:hip circumference.
Table 2: Univariate risk factors of ischemic stroke amongHIV/AIDS patients.
Variables of interest Presence of stroke n (%) Absence of stroke n (%) P value
High SES 17 (100) 19 (19.2) <.0001
Men 16 (94.1) 38 (38.4) <.0001
Physical inactivity 16 (94.1) 45 (45.5) <.0001
Smoking 17 (100) 9 (9.1) <.0001
Excessive alcohol 16 (94.1) 28 (28.6) <.0001
Total obesity 16 (94.1) 36 (46.2) <.0001
Hypertension 17 (100) 17 (16.2) <.0001
Heart failure 16 (94.1) 9 (9.1) <.0001
Myocardial infarction 16 (94.1) 2 (2) <.0001
Type 2 diabetes 16 (94.1) 5 (5.1) <.0001
Gout 16 (94.1) 0 (0) <.0001
Autoimmunity 16 (94.1) 36 (46.2) <.0001
Pulse pressure ≥60mmHg 16 (94.1) 18 (18.2) <.0001
ARV exposure 17 (100) 34 (34.3) <.0001
3.Results
There were 54 men and 62 women with a female to male
ratio 1.2:1. The mean age of male patients (45.3 ± 8.5 years;
P = .132) was similar with that of female patients (42.5 ±
11.2 years).
Stroke was the ﬁrst clinical manifestation of HIV infec-
tion in 12 patients. Isolated hemiparesis, hemianopia, and
aphasiawerepresentin4patients,3patients,and10patients,
respectively.
CT scan revealed ischemic stroke in the majority of cases
(n = 17): 14 cases of infarcts occurred in the anterior
circulation and 3 cases of infarcts occurred in the posterior
circulation. Only 1 patient had supratentorial hemorrhagic
stroke while no hemorrhagic infarcts or venous strokes were
reported. Carotid Doppler reports revealed no lesions in the
onlypatientwith hemorrhagic strokeandinonepatient with
ischemic stroke but elevated intima-media thickness in 15
stroke cases. Cerebral angiography was not available.
HIV-related dilated cardiomyopathy, atrial ﬁbrillation,
elevated circulating immune complexes, protein C deﬁ-
ciency,proteinS deﬁciency,disseminated intravascular coag-
ulation, D-dimer ≥500ug/L, elevated highly sensitive C-
reactive protein, insulin resistance, elevated level of antibod-
ies against oxidized LDL-cholesterol, and antiphospholipid
syndrome were similarly (P>. 05) frequent in the group
with ischemic stroke (n = 1 7 )a n dt h eg r o u pw i t h o u ts t r o k e
(n = 99).
There was a signiﬁcant association between lowerlevel of
CD4+ count, higher levels of WC, HC, glucose, hematocrit,
pulse pressure, and the presence of ischemic stroke (Table 1).
There was a signiﬁcant association between high SES
males 29.6%, n = 16 versus, 1.6% n = 1 females),
physical inactivity, current cigarette smoking, excessive alco-
h o li n t a k e ,t o t a lo b e s i t y ,a r t e r ial hypertension, congestive
heart failure, myocardial infarction, type 2 diabetes, gout,
autoimmunity, pulse pressure ≥60mmHg, ﬁrst-line ARV
exposure, and the presence of ischemic stroke (Table 2). The
majority ofischemic stroke cases were at WHO AIDSStage 4
(n = 13/19) and Stage 3 (n = 3/12).
4.Discussion
We found that the majority (n = 17/18) had ischemic stroke
and only 1 patient had hemorrhagic stroke in accordance
with few reports [3, 19], but contrasting a much higher rate
of intracerebral haemorrhage in most of the reported series
[20–22].4 ISRN Cardiology
4.1. Mechanisms of All Stroke Subtypes. Several clinical,
imaging, and autopsy studies have observed a greater-
than-chance association between HIV infection and stroke
[4, 20–23]. Both types of stroke were frequently asso-
ciated with concomitant central nervous system disease
(opportunisticinfections, andtumors)[3].Intravenousdrug
abuse infrequently reported as cause of stroke (underlying
vasculitis, vasoconstriction, and immunologic mechanisms)
from developed countries [19], opportunistic vasculitis, vas-
culopathy, meningitis, Toxoplasma gondii, Cytomegalovirus,
syphilis, or Cryptococcus [9–15, 19]a r en o tr e p o r t e di n
this study. Cardioembolism due to dilated cardiomyopathy,
atrial ﬁbrillation, protein S deﬁciency, protein C deﬁciency,
hypercoagulability, abdominal lymphomas, and dissemi-
nated Kaposi’s sarcomas were common in this study as
reported by other studies [3, 4, 19–23].
4.2.Mechanisms ofIntracerebral Haemorrhage. Uncontrolled
hypertension was identiﬁed as the possible cause of hemor-
rhagic stroke. This situation may be explained by the decline
of most of the conditions conferring an increased risk of
intracerebral haemorrhage in recent years [19].
4.3. Mechanisms of Ischemic Stroke. For the ﬁndings to be
meaningful, one has to compare our data with those on
young black HIV-positive patients [3]a n dy o u n gH I V -
negative black African patients [5–8, 24]w i t hs t r o k e .C o a g -
ulopathies, insulin resistance, metabolic syndrome, lifestyle
changes, and autoimmunity were not reported in young
HIV-negative African patients [20, 21]. Coagulopathies and
autoimmunitybutnotinsulinresistanceandlifestylechanges
were reported in young HIV-positive African patients [3].
Ourdatashow that severityofHIVdisease, low CD4+count,
insulin resistance, autoimmunity, metabolic syndrome, total
obesity, hypertension, type 2 diabetes, gout, myocardial
infarction, and ischemic stroke are emerging in Central
Africans with HIV/AIDSbecause of demographic transition,
lifestyle changes, low CD4+ count, ARV exposure, and later
stages of HIV disease, but not from atherogenic dyslipi-
daemia [25, 25] .T h er a t e so fm o d i ﬁ a b l er i s ki n d i c a t o r so f
ischemic stroke in these HIV/AIDS patients are impressively
higher than those frequently reported in uninfected and
infected individuals worldwide [26, 27]. The main emphasis
i nt h em a n a g e m e n to fi s c h e m i cs t r o k es h o u l db eo np r o f e s -
sionally supervised lifestyle changes, particularly eﬀorts to
smoking cessation, reduce body weight and alcohol intake,
and increase moderate physical activity. Elevated blood
pressure and hyperglycaemia may, however, need additional
drug treatment.
Young age, autoimmunity, and metabolic syndrome,
identiﬁed as independent risk factors of ischemic stroke
in this study, may explain atherosclerosis in these black
Central African HIV/AIDS patients. Approximately 50%
of atherosclerotic coronary artery disease in developed
populations occurs in the absence of traditional risk fac-
tors, such as smoking, hypertension, diabetes mellitus, and
hypercholesterolemia [28]. Over 80–100% of atherosclerotic
stroke and coronary heart disease in Central Africans occur
with normal lipid proﬁle, hyperuricemia, and infections
(Helicobacter pylori, and bacterial pneumonia) [5–8].
The present study shows that all HIV/AIDS patients had
elevated hs-CRP levels and antibodies against oxidized LDL
cholesterol in terms of oxidativestress, proinﬂammatory and
chronic inﬂammation. Chronic inﬂammation may act inde-
pendently or synergistically with traditional atherosclerotic
risk factors in the pathogenesis of atherosclerotic stroke and
may also be associated with a hypercoagulable state (elevated
D-Dimer, high hematocrit, protein C deﬁciency, protein S
deﬁciency) in these HIV/AIDS patients [29, 30].
The present ﬁndings conﬁrm the unclear role of
autoimmunity as directly pathogenic or simple marker of
arterial disease in stroke of HIV/AIDS patients. A host
tissue component may become antigenic when altered
by a drug or proatherosclerotic eﬀects of HIV infection-
related endothelial dysfunction [19]. In HIV/AIDS patients,
autoantibodies and the associated release of tumor necrosis
factor-α have been revealed to reduce proteins activity [30].
Elevated antiphospholipid IgG antibody titers and circulat-
ing immune complex were found in HIV/AIDSpatientswith
and without ischemic stroke [3, 31]. Insulin resistance is
an independent risk factor for atherosclerosis in rheumatoid
arthritis [32].
4.4. Limitations. The limitations of this study are related to
the observational design and cross-sectional nature of the
current analyses as well as the small size of stroke cases and
the clinical status of the population studied. In this respect,
the results reported herein are only associations from which
no conclusions regarding causality can be drawn. Further
studies with HIV negatives are needed to demonstrate the
independent role of HIV infection itself from HAART and
metabolic factors. Early assessment of the vascular status,
continuous monitoring of drugs, and Preventive Cardiology
approach in HIV-infected patients are suggested.
In this hospital-based study, mild or minor ischemic
strokes probably went undetected.
5.Conclusions
Stroke in patients with HIV/AIDS was not associated
with opportunistic infections and tumors. Autoimmunity,
younger age, and metabolic syndrome are associated with
ischemic stroke. Early assessment of the vascular status,
continuous monitoring of drugs, and Preventive Cardiology
approach in HIV-infected patients are suggested.
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